A new statistical technique developed by a researcher at the Texas A&M University School of Public Health and colleagues ...
A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
A biotech that uses artificial intelligence to assist its drug discovery efforts has relocated its headquarters from New York ...
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...
The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...
IPF is a rare progressive fibrosing interstitial lung disease with symptoms that include breathing difficulty, dry and persistent cough, chest discomfort and fatigue. The randomized, double-blind, ...
Albert Agro, PhD, CMO of GRI Bio recently participated in a Virtual Investor KOL Connect segment with prominent key opinion leader in Idiopathic Pulmonary Fibrosis (IPF) – Dr. Helen Parfrey, ...
Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses recent advancements in clinical trials for patients with idiopathic pulmonary fibrosis (IPF) and progressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback